PCUK News - New guidelines to prompt doctors to offer men active surveillance for low risk cancers
Thursday, 23rd May 2019
News this month from a PCUK email......
Long after the cancer has been treated, surgery or radiotherapy can have an impact on men's lives. So we're pleased to share two pieces of good news that may mean fewer side effects for men diagnosed in the future.
New guidelines released last week for doctors in England and Wales will encourage active surveillance for men with low risk cancer, which can help delay or avoid treatment side effects. Read our article for details on the other changes being introduced and how we're helping doctors to advise men about treatment options.
As NICE release updated guidelines to endorse active surveillance alongside surgery and radiotherapy as treatment options, PCUK publish advice for doctors on how to help men feel confident in making the choice.
New guidelines released last week for doctors in England and Wales will encourage active surveillance for men with low risk cancer, which can help delay or avoid treatment side effects. Read our article for details on the other changes being introduced and how we're helping doctors to advise men about treatment options.
As NICE release updated guidelines to endorse active surveillance alongside surgery and radiotherapy as treatment options, PCUK publish advice for doctors on how to help men feel confident in making the choice.
Men must receive support for choosing active surveillance as new guidelines provide endorsement
We publish new best practice guidelines for doctors offering active surveillance to men, as NICE today recognise the procedure as being on a par with surgery and radiotherapy for men with low risk localised prostate cancer.